SpringWorks Opens Above IPO Price

Springworks Therapeutics, Inc. SWTX made its public debut Friday morning, opening at $24.50 after being priced between $16 and $18 per share.

The company's shares have been listed on the Nasdaq under the ticker symbol "SWTX."

Springworks Therapeutics IPO: What You Need To Know

Springworks, founded in August 2017, is a clinical-stage biopharma company applying a precision medicine approach to develop medicines for rare diseases and cancer. It has a differentiated portfolio of small molecule targeted oncology product candidates.

JPMorgan, Goldman Sachs, Cowen and Wedbush PacGrow are the underwriters for the offering.

Posted In: NewsIPOs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...